Preeclampsia: A danger growing in disguise

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 10, 2008, Pages 1979-1983

  Irminger Finger, Irmgard ^a   Jastrow, Nicole ^b   Irion, Olivier ^b  

^a Laboratoire de Gynécologie Obstétrique Moléculaire   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Cytotrophoblast; Endoglin; Flt 1; HELLP; Preeclampsia; VEGF

Indexed keywords

ANTIHYPERTENSIVE AGENT; MAGNESIUM SULFATE;

ANTICONVULSANT THERAPY; BLOOD PRESSURE REGULATION; DELIVERY; ECLAMPSIA; ENDOTHELIAL DYSFUNCTION; HUMAN; MOLECULAR MECHANICS; PATHOGENESIS; PREECLAMPSIA; SHORT SURVEY; SIGNAL TRANSDUCTION; TROPHOBLAST;

FEMALE; HUMANS; ORGAN SPECIFICITY; PRE-ECLAMPSIA; PREGNANCY; SIGNAL TRANSDUCTION;

EID: 47649101201     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.04.006     Document Type: Short Survey

References (32)

1. Allaire A.D., Ballenger K.A., Wells S.R., McMahon M.J., and Lessey B.A. Placental apoptosis in preeclampsia. Obstet Gynecol 96 (2000) 271-276
2. Altman D., Carroli G., Duley L., Farrell B., Moodley J., Neilson J., et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 359 (2002) 1877-1890
3. Arias F., and Mancilla-Jimenez R. Hepatic fibrinogen deposits in pre-eclampsia. immunofluorescent evidence. N Engl J Med 295 (1976) 578-582
4. Bischof P., and Irminger-Finger I. The human cytotrophoblastic cell, a mononuclear chameleon. Int J Biochem Cell Biol 37 (2005) 1-16
5. Brosens I.A., Robertson W.B., and Dixon H.G. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1 (1972) 177-191
6. Duckitt K., and Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330 (2005) 565
7. Ferris T.F. Pregnancy, preeclampsia, and the endothelial cell. N Engl J Med 325 (1991) 1439-1440
8. Germain S.J., Sacks G.P., Sooranna S.R., Sargent I.L., and Redman C.W. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 178 (2007) 5949-5956
9. Gu Y., Lewis D.F., and Wang Y. Placental productions and expressions of sEndoglin, sFlt-1, and PlGF in normal and preeclamptic pregnancies. J Clin Endocrinol Metab (2007)
10. Hiby S.E., Walker J.J., O'Shaughnessy K.M., Redman C.W., Carrington M., Trowsdale J., et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 200 (2004) 957-965
11. Hiby S.E., Regan L., Lo W., Farrell L., Carrington M., and Moffett A. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum Reprod (2008)
12. Higuchi S., Ohtsu H., Suzuki H., Shirai H., Frank G.D., and Eguchi S. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond) 112 (2007) 417-428
13. Ishihara N., Matsuo H., Murakoshi H., Laoag-Fernandez J.B., Samoto T., and Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 186 (2002) 158-166
14. Kadyrov M., Schmitz C., Black S., Kaufmann P., and Huppertz B. Pre-eclampsia and maternal anaemia display reduced apoptosis and opposite invasive phenotypes of extravillous trophoblast. Placenta 24 (2003) 540-548
15. King A., Loke Y.W., and Chaouat G. NK cells and reproduction. Immunol Today 18 (1997) 64-66
16. Li L., Cohen M., Wu J., Sow M.H., Nikolic B., Bischof P., et al. Identification of BARD1 splice-isoforms involved in human trophoblast invasion. Int J Biochem Cell Biol (2007)
17. Lyall F. Mechanisms regulating cytotrophoblast invasion in normal pregnancy and pre-eclampsia. Aust N Z J Obstet Gynaecol 46 (2006) 266-273
18. Magee L.A., Miremadi S., Li J., Cheng C., Ensom M.H., Carleton B., et al. Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol 193 (2005) 153-163
19. Moran P., Lindheimer M.D., and Davison J.M. The renal response to preeclampsia. Semin Nephrol 24 (2004) 588-595
20. Naicker T., Khedun S.M., Moodley J., and Pijnenborg R. Quantitative analysis of trophoblast invasion in preeclampsia. Acta Obstet Gynecol Scand 82 (2003) 722-729
21. Rajakumar A., Michael H.M., Rajakumar P.A., Shibata E., Hubel C.A., Karumanchi S.A., et al. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women. Placenta 26 (2005) 563-573
22. Redman C.W. Current topic: pre-eclampsia and the placenta. Placenta 12 (1991) 301-308
23. Roberts J.M. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 16 (1998) 5-15
24. Roberts J.M., and Gammill H.S. Preeclampsia: recent insights. Hypertension 46 (2005) 1243-1249
25. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., and McLaughlin M.K. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161 (1989) 1200-1204
26. Saftlas A.F., Olson D.R., Franks A.L., Atrash H.K., and Pokras R. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol 163 (1990) 460-465
27. Sibai B.M. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 103 (2004) 981-991
28. Sibai B.M., Kustermann L., and Velasco J. Current understanding of severe preeclampsia, pregnancy-associated hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, hemolysis, elevated liver enzymes, and low platelet syndrome, and postpartum acute renal failure: different clinical syndromes or just different names?. Curr Opin Nephrol Hypertens 3 (1994) 436-445
29. Spencer K., Cowans N.J., and Nicolaides K.H. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Prenat Diagn (2007)
30. Stamilio D.M., Sehdev H.M., Morgan M.A., Propert K., and Macones G.A. Can antenatal clinical and biochemical markers predict the development of severe preeclampsia?. Am J Obstet Gynecol 182 (2000) 589-594
31. Venkatesha S., Toporsian M., Lam C., Hanai J., Mammoto T., Kim Y.M., et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12 (2006) 642-649
32. Xia Y., Ramin S.M., and Kellems R.E. Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia. Hypertension 50 (2007) 269-275